Welcome to the InfoSci Platform
Reference Hub1
Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment

Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment

Maria Vlasova, Boris V. Smirin
Copyright: © 2017 |Pages: 21
ISBN13: 9781522507543|ISBN10: 152250754X|EISBN13: 9781522507550
DOI: 10.4018/978-1-5225-0754-3.ch001
Cite Chapter Cite Chapter

MLA

Vlasova, Maria, and Boris V. Smirin. "Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment." Recent Advances in Drug Delivery Technology, edited by Raj K. Keservani, et al., IGI Global, 2017, pp. 1-21. https://doi.org/10.4018/978-1-5225-0754-3.ch001

APA

Vlasova, M. & Smirin, B. V. (2017). Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment. In R. Keservani, A. Sharma, & R. Kesharwani (Eds.), Recent Advances in Drug Delivery Technology (pp. 1-21). IGI Global. https://doi.org/10.4018/978-1-5225-0754-3.ch001

Chicago

Vlasova, Maria, and Boris V. Smirin. "Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment." In Recent Advances in Drug Delivery Technology, edited by Raj K. Keservani, Anil K. Sharma, and Rajesh Kumar Kesharwani, 1-21. Hershey, PA: IGI Global, 2017. https://doi.org/10.4018/978-1-5225-0754-3.ch001

Export Reference

Mendeley
Favorite

Abstract

This chapter characterizes need for new patient-specific approaches in medicine. The authors here illustrate role of nanomedicine and particularly nanotheranostics, combining diagnostic and therapeutic functions, in the paradigm of personalized disease treatment. This chapter discusses current insights regarding the mechanisms of nano-bio interactions and the origin of adverse effects of nanoformulations. Furthermore, this chapter illustrates possible reasons behind an individual physiological response to a given nanomedicine, such as type and stage of disease, physiological conditions and lifestyle of a patient. Finally, a review of possible approaches for the initial choice of nanoformulation, suitable for a given patient is provided at the end of the chapter.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.